Company Filing History:
5 out of 9 
2 out of 4 
1 out of 1 Years Active: 2003-2025
Title: Shmuel Bukshpan: Innovator in Mitochondrial Augmentation Therapy
Introduction
Shmuel Bukshpan is a prominent inventor based in Ramat Hasharon, Israel. He has made significant contributions to the field of mitochondrial augmentation therapy, focusing on treatments for brain and renal diseases. With a total of 12 patents to his name, Bukshpan's work is paving the way for innovative therapeutic approaches.
Latest Patents
Among his latest patents, Bukshpan has developed groundbreaking methods for treating brain diseases through mitochondrial augmentation therapy. His invention provides stem cells enriched with healthy functional mitochondria, along with pharmaceutical compositions that utilize these cells. This therapy aims to address brain diseases, disorders, and symptoms, regardless of whether they are associated with acquired mitochondrial dysfunction. Additionally, he has created a similar therapeutic approach for renal diseases, offering new hope for patients suffering from these conditions.
Career Highlights
Shmuel Bukshpan has worked with Minovia Therapeutics Ltd., where he has been instrumental in advancing research and development in mitochondrial therapies. His expertise and innovative mindset have positioned him as a key figure in this emerging field.
Collaborations
Bukshpan has collaborated with notable professionals in his field, including Uriel Halavee and Natalie Yivgi Ohana. These partnerships have further enhanced his research and contributed to the success of his inventions.
Conclusion
Shmuel Bukshpan's work in mitochondrial augmentation therapy represents a significant advancement in medical science. His innovative patents and collaborations are set to make a lasting impact on the treatment of brain and renal diseases.